UBS Downgrades Impax Laboratories To Sell By: Benzinga via Benzinga April 17, 2015 at 09:05 AM EDT Analysts at UBS downgraded Impax Laboratories Inc (NASDAQ: IPXL) from Neutral to Sell. Impax Laboratories shares have gained 99.84 ... Read More >> Related Stocks: UBS Group Ag ADR